The first thing my patients tell me when they feel inquiring on Thai stem cell Parkinson is about dopamine. That makes sense. Parkinson’s disease is entirely associated with the death of neurons that produce dopamine in a specific area of our brain, and most common treatments aim to increase dopamine activity.
However, Parkinsons disease is not a dopamine problem only. The disease itself is also an inflammatory condition, oxidative stress process, mitochondrial dysfunction activity, cell signaling shifts in the immune field gut-brain interaction fields motor function loss balance weakness sleep pattern change moods through low physical stamina teransgenteration changes. Parkinson’s is a progressive disorder of the nervous system that affects movement, and may also cause sleep, mood or cognitive change.
This is the reason modern regenerative medicine has an eye on everything except dopamine.
Understanding Parkinson’s Beyond Dopamine
Dopaminergic substitution is among the most effective symptomatic treatments, particularly for rigidity, bradykinesia and postural impairment. But the biological processes of Parkinson’s disease aren’t covered completely by medication.
Whereas, several patients still complain of fatigue, poor balance, freezing – refraining from moving forward during walking or other modes of ambulation -, tremor fluctuation changes along the course day (ON vs OFF), sleep disturbance / insomnia and reviewing constipation in addition to brainfog: reduced confidence when performing activities required for demonstrating movement scoring. Long-term, the condition may inevitably be multifaceted and necessitate pharmacological treatment along with rehabilitation, nutrition chronic sleep aid when necessary as well as fall precautions and monitoring.
As a physician, I caution patients by saying that stem cell therapy should not be viewed as an alternative to Parkinson’s medication. Which is not yet needed or appropriate, only for regenerative medicine considerations if it will be supportive when discussed.
Stem Cell Therapy: How It May Help with Parkinson’s Disease
Stem cell therapy for Parkinson’s disease in various aspects is investigated Advanced research programs are looking at replacement of dopamine-producing cells. However, UC-MSC stem cell therapy is different. Umbilical cord-derived mesenchymal stem cells are excluded on account of their propensity to develop into new dopamine neurons directly through very predictable differentiations.
Cellular communication gives a better understanding of what the primary function
UC-MSC stem cell therapy can secrete growth factors, cytokines, extracellular vesicles and microRNAs. These signaling molecules may also target immune cells, vascular cell and stressed tissue microenvironment. UC-MSC stem cell therapy have been described as “medicinal signaling cells” because their therapeutic interest usually relates to systems of secreted biological signals, rather than purely through tissue replacement.
This signalling paradigm is important for Parkinson’s disease because of the background level of neuroinflammation and oxidative stress generated by a chronic diseased environment in which neurons must function. Both preclinical and translational studies suggest that MSC-derived extracellular vesicles may have modulatory effects on neuroinflammation, oxidative stress and cell-to-cell communication in various models of neurodegeneration; however clinical protocols are not yet established treatment as evidence is required to ensure the applicability into human disease.
The case for DFPP ahead of treatment
In some regeneration medicine centers, DFPP prior to stem cell therapy is discussed for specific patients. DFPP is a blood purification method including double filtration plasmapheresis, separating plasma from the other components of human blood and filters <500 kDa size molecules followed by return hemo-component to vivo body.
Figure 1: How Stem Cell Therapy, DFPP Preparation, and Rehabilitation May Support Parkinson’s Disease Care
The aim is not to “treat Parkinson’s per se.” A more appropriate justification is that DFPP may serve as a preparatory step in patients at high inflammatory burden,i.e., those with vascular risk factors, lipid-deranged profiles or immune parity imbalance. More recent reviews have described DFPP as an adjunctive method of plasma purification to remove certain selected circulating substances (specific immune-related proteins and lipid-related components, according to the indication) via specific filters.
The rationale for patients with Parkinson, is supportive: if lots of inflammation or poor circulation and/or metabolic stress are ongoing within the body then relieving some condition that restricts blood flow to periphery may be plump in their perception-based endosome ahead cellular treatment. This should always be a medical decision and never something expected as the norm of process for every patient.
Rehabilitation Still Matters
Rehabilitation remains an integral part even when you add stem cell therapy. It affects movement patterns, balance, posture a particular rhythm to walking and muscle control functions as well all the daily living movements. Exercise and physical therapy are strongly emphasized in Parkinson’s care since they can help maintain functional mobility, flexibility, posture/balance as well as activities of daily living.
I usually tell patients:
UC-MSC stem cell therapy could promote dysbiological signaling but rehabilitate the nervous system to move.
An effective program can even entail gait training, balance work, strengthening exercises, stretching routines and posture practice (if that is an issue), coordination workouts; in certain cases occupational therapy or speech/swallowing support as well.
Who Can Handle A Candidate Better?
However, better candidates may be found when the patient is medically stable and has realistic expectations from it while he or she can still participate in rehabilitation. It could be enhanced energy, muscle performance support, inflammatory burden reduction and/or recovery capacity management or better quality of Life.
Regenerative medicines are not to be used on patients who have unstable heart disease, active infection, uncontrolled cancer (eg metastatic), severe blood disorders or any serious medical instability which requires physician consideration before treatment can be provided.
Final Thoughts
Stem cell is a supportive therapy for Parkinson disease in Thailand. It does not substitute for dopamine medication, neurologist care or rehabilitation.
A responsible program sees Parkinson’s more comprehensively: dopamine function, cellular signaling, inflammation homeostasis and circulation, metabolic status/health essential outcomes physical therapy patient safety. When DFPP is indicated prior to treatment, it should be justified as preparation for selected patients and not a method to enhance outcomes.
For patients, the most important question is not just simply this: “Can stem cells cure Parkinson’s disease?”
The better question is: Am I medically fit, and can my body work to the combined effort of regenerative signaling (DFPP preparation when warranted) followed by a defined rehabilitation plan?